Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ware

Showing results (381-390 of 428) with videos related to

Pageof 43
Sort By:
The Oncologist|August 12, 2017
A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid TumorsStephen Leong, Rebecca A Moss, Daniel W Bowles, et al.
Molecular Pharmaceutics|September 19, 2013
Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical developmentGillian S Smelick, Timothy P Heffron, Laura Chu, et al.
Canadian Journal of Pain = Revue Canadienne De La Douleur|January 10, 2022
Multicenter assessment of quantitative sensory testing (QST) for the detection of neuropathic-like pain responses using the topical capsaicin modelCatherine E Ferland, Chantal Villemure, Pierre-Emmanuel Michon, et al.
American Journal of Medical Genetics. Part A|November 16, 2019
Growth hormone deficiency in megalencephaly-capillary malformation syndrome: An association with activating mutations in PIK3CAShanlee Davis, Meredith A Ware, Jordan Zeiger, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|September 24, 2020
Overview of the Canadian Clinician Investigator Trainees' research presented at the 2019 CSCI-CITAC Joint MeetingValera Castanov, Tianwei E Zhou, Christopher S Balestrini, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 15, 2015
Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study designCaroline A Lee, Meeghan A O'Connor, Tasha K Ritchie, et al.
Arthritis Care & Research|July 25, 2022
Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort StudyRomina Sotoodeh, Lilach Eyal Waldman, Antonio Vigano, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasisHenriette E Meyer zu Schwabedissen, Joseph A Ware, David Finkelstein, et al.
European Journal of Pain (London, England)|October 15, 2016
Pain expectations in neuropathic pain: Is it best to be optimistic?G P Bostick, S J Kamper, T M Haanstra, et al.
Obesity (Silver Spring, Md.)|March 5, 2024
Metabolic effects of an essential amino acid supplement in adolescents with PCOS and obesityTalyia M Fordham, Nazeen S Morelli, Yesenia Garcia-Reyes, et al.
Pageof 43

Showing results (381-390 of 428) with videos related to

Sort By:
Pageof 43
The Oncologist|August 12, 2017
A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid TumorsStephen Leong, Rebecca A Moss, Daniel W Bowles, et al.
Molecular Pharmaceutics|September 19, 2013
Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical developmentGillian S Smelick, Timothy P Heffron, Laura Chu, et al.
Canadian Journal of Pain = Revue Canadienne De La Douleur|January 10, 2022
Multicenter assessment of quantitative sensory testing (QST) for the detection of neuropathic-like pain responses using the topical capsaicin modelCatherine E Ferland, Chantal Villemure, Pierre-Emmanuel Michon, et al.
American Journal of Medical Genetics. Part A|November 16, 2019
Growth hormone deficiency in megalencephaly-capillary malformation syndrome: An association with activating mutations in PIK3CAShanlee Davis, Meredith A Ware, Jordan Zeiger, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|September 24, 2020
Overview of the Canadian Clinician Investigator Trainees' research presented at the 2019 CSCI-CITAC Joint MeetingValera Castanov, Tianwei E Zhou, Christopher S Balestrini, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 15, 2015
Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study designCaroline A Lee, Meeghan A O'Connor, Tasha K Ritchie, et al.
Arthritis Care & Research|July 25, 2022
Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort StudyRomina Sotoodeh, Lilach Eyal Waldman, Antonio Vigano, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasisHenriette E Meyer zu Schwabedissen, Joseph A Ware, David Finkelstein, et al.
European Journal of Pain (London, England)|October 15, 2016
Pain expectations in neuropathic pain: Is it best to be optimistic?G P Bostick, S J Kamper, T M Haanstra, et al.
Obesity (Silver Spring, Md.)|March 5, 2024
Metabolic effects of an essential amino acid supplement in adolescents with PCOS and obesityTalyia M Fordham, Nazeen S Morelli, Yesenia Garcia-Reyes, et al.
Pageof 43